Skip to content
Subscriber Only

Glaxo Malaria Vaccine Works for at Least 15 Months, Study Shows

GlaxoSmithKline Plc’s experimental malaria vaccine, already shown to cut the risk of children contracting the disease by half after 8 months, was equally effective after 15, a study showed.

Youngsters in Africa who got the shot, called Mosquirix, were 46 percent less likely to contract malaria than those who received a rabies vaccine, according to the study published in the journal Lancet Infectious Diseases.